Olopatadine (Allodrop)
Olopatadine
Ipharma (Pty) Ltd
Registration
- Applicant
- Ipharma (Pty) Ltd
- Certificate holder
- Ipharma (Pty) Ltd
- Registrations
- 1
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Allodrop Each 1 ml contains OLOPATADINE HYDROCHLORIDE EQUIVALENT TO OLOPATADINE 1,0 mg | 1 mg/mlEye drops, solution | 49053849/15.4/0538Approved 31 August 2022 | Registered | Not determined | PIL |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
2-[(11Z)-11-[3-(Dimethylamino)propylidene]-6H-benzo[c][1]benzoxepin-2-yl]acetic acid
Drag to rotate. Structure from PubChem CID 5281071.
SAHPRA documents
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.